| Application no. and date | 17842428.9 (espacenet) (Federated) (European Patent Register), 20171102 | | Patent/reg. no. and date | DK/EP 3534885, 20210120 | | Publication date | 20190911 | | Priority no. and date | US 201662417044 P, 20161103 | | EP pub. no. and date |
EP 3534885 20190911 | | Effective date | | | Applicant/owner | Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400
San Diego, CA 92130, US | | Applicant ref. no. | P76133DK01 | | Inventor | GUALBERTO, Antonio, 8 Larch Road
Acton, MA 01720, US,
SCHOLZ, Catherine Rose, 8 James Millen Road
North Reading,MA 01864, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/4709 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) , C12Q 1/68 (2018.01) , C12Q 1/6886 (2018.01) | | Title | FARNESYLTRANSFERASE-INHIBITORER TIL ANVENDELSE I BEHANDLING AF KRÆFT | | Int. application no. | US2017059686 | | Int. publication no. | WO2018085518 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
